Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8602)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2024 (publication date) through Jan 28, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Guney-Coskun M, Basaranoglu M. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World J Gastroenterol 2024; 30(43): 4682-4688 [PMID: 39575401 DOI: 10.3748/wjg.v30.i43.4682] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Guney-Coskun M, Basaranoglu M. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World J Gastroenterol 2024; 30(43): 4682-4688 [PMID: 39575401 DOI: 10.3748/wjg.v30.i43.4682] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i43/4682.htm |
| Number | Citing Articles |
| 1 |
Jingyue Wang, Jing Qu, Mengliang Ye, Ru Feng, Xiang Hui, Xinyu Yang, Jingyu Jin, Qian Tong, Xianfeng Zhang, Yan Wang. Beyond conventional therapies: Gut microbiota modulation and macromolecular drugs in the battle against cardiometabolic diseases. Journal of Pharmaceutical Analysis 2026; 16(1): 101416 doi: 10.1016/j.jpha.2025.101416
|
| 2 |
Danyang Zhang, Haitao Shi, Chongcao Wei, Fenrong Chen, Pan Zhang, Xin Gao, Yan Wang. Analysis of causal effects on metabolic syndrome and inflammatory bowel disease: a Mendelian randomization study. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01704-w
|
| 3 |
Shengnan Meng, Luonan Li, Shijie Yin, Yuxuan Zhao, Yaning Liu, Yuxi Zhang, Xiaolin Zhang, Fengxue Yu. The newly proposed dietary index for gut microbiota and its association with the risk of nonalcoholic fatty liver disease: the mediating role of body mass index. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01801-w
|
| 4 |
Afianti Sulastri, Dewi Cakrawati, Aldi Maulana Azis. Organ-Specific Modulation of IGF-Binding Proteins in Malnourished Mice Supplemented with Probiotics: A Proteomic Approach. BIO Web of Conferences 2026; 209: 03001 doi: 10.1051/bioconf/202620903001
|
| 5 |
Luis A. Rodríguez-Rojas, Leticia Bucio-Ortiz, Verónica Souza-Arroyo, María Concepción Gutiérrez-Ruiz, Luis E. Gómez-Quiroz, Roxana U. Miranda-Labra. Cholesterol and the gut-liver axis: unraveling their role in the onset and progression of metabolic-associated steatotic liver disease. Exploration of Digestive Diseases 2025; doi: 10.37349/edd.2025.100583
|
| 6 |
Junmei Huang, Hao Cheng. Effects of Bifidobacterium on metabolic parameters in overweight or obesity adults: a systematic review and meta-analysis. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1633434
|
| 7 |
Luigi Barrea, Giuseppe Annunziata, Ludovica Verde, Martina Galasso, Silvia Savastano, Annamaria Colao, Giovanna Muscogiuri. A Multidisciplinary Perspective on Semaglutide Treatment and Medical Nutrition Therapy in Obesity Management. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-025-00667-3
|
| 8 |
Mehmet Kanbay, Rama Al-Shiab, Ermeena Shah, Lasin Ozbek, Mustafa Guldan, Alberto Ortiz, Denis Fouque. Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes. Clinical Kidney Journal 2025; 18(12) doi: 10.1093/ckj/sfaf351
|
| 9 |
Xueting Zheng, Xiaoyan Luo, Yi Zhang, Zhiyan Zou, Jiayi Yang, Huan Liu, Zhou Lu, Fangfang Cao, Xilian Wang, Xinyun Ge, Xiaoan Li, Jiali Wang. Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance. Journal of Diabetes 2025; 17(12) doi: 10.1111/1753-0407.70175
|
| 10 |
Hao Zhang, Yuan Tian, Chunjie Xu, Miaomiao Chen, Zeyu Xiang, Lei Gu, Hanbing Xue, Qing Xu. Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02364-5
|
| 11 |
Zoubiri Houda, Saiah Wassila, Otmane Amel, Saidi Hamza, Makrelouf Mohamed, Aitabderrhmane Samir, Haddam Ali El Mahdi, Koceir Elhadj-Ahmed. Plasma GLP-1 (Glucagon-like Peptide-1) Depletion Is Correlated with Dysregulation of Adipocytokine in Type 2 Diabetic Patients With or Without Metabolic-Associated Fatty Liver Disease (MAFLD): A Cross-Sectional Study Related to Gender-Sex Disparities. International Journal of Molecular Sciences 2026; 27(3): 1218 doi: 10.3390/ijms27031218
|